IGC 8-K Presentation on its Life Sciences business

December 20, 2022

December 20, 2022

IGC 8-K Presentation on its Life Sciences business

Related Posts

IGC Pharma DEF 14A 07-05-24 AS FILED

July 12, 2024

IGC FYE2024 Annual Meeting PROXY CARD

July 9, 2024

Annual Shareholder Letter July 2024

July 9, 2024

CEO Update

Desk of CEO Marijuana Reclass

July 25, 2024

alzheimer

6.7 Million Americans Live With Alzheimer’s – IGC Pharma Believes They Deserve Treatment Options Without Black Box Warnings

May 8, 2024